You searched for "vitrectomy"
Caffeine concentration in the vitreous after drinking coffee
7 April 2021
| Ed Rule
|
EYE - Vitreo-Retinal
Caffeine is known to penetrate many bodily fluids, including the vitreous. In this prospective study, investigators measured caffeine levels in vitreous samples from patients undergoing vitrectomy and epiretinal membrane peel. Patients were divided into habitual and non-habitual coffee drinkers. One...
Occurrence and risk factors for RD after PPV in acute postcataract bacterial endophthalmitis
1 February 2017
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a prospective multicentre study from France between March 2004 to December 2011 in four university hospitals; 123 consecutive patients treated with pars planar vitrectomy (PPV) were included in this cohort. The rate of retinal detachment (RD) of post-PPV...
ILM peeling in primary rhegmatogenous retinal detachment
1 June 2015
| Saruban Pasu
|
EYE - Vitreo-Retinal
This author retrospectively analysed the correlation between internal limiting membrane (ILM) peeling and the occurrence of a postoperative epiretinal membrane (ERM) in patients who underwent vitrectomy for rhegmatogenous retinal detachment (RD). There were 135 medical records investigated. Seventy patients underwent...
Diagnostic procedures in vitreoretinal lymphoma.
1 December 2014
| Nikolaos D Georgakarakos
|
EYE - Vitreo-Retinal
This paper presented a retrospective review of medical records of HIV negative immunocompetent patients diagnosed with vitreoretinal lymphoma between 1994 and 2012. The aim of the paper was to evaluate the type and number of diagnostic interventions required to confirm...
RCT of operative routes for congenital cataract surgery
The authors evaluated the performance of 25G vitrectomy systems in the management of congenital cataract in infants through two routes – anterior (transcorneal) and posterior (pars plana). This was a prospective randomised trial (RCT) of 24 eyes of 12 patients...Infliximab in treatment of PVR
28 February 2025
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
In this phase 2 randomly controlled trial, 66 patients with primary rhegmatogenous retinal detachment and grade C proliferative vitreoretinopathy (PVR) were randomised in a 1:1 ratio to undergo pars plana vitrectomy (PPV) and silicone oil (SO) injection with or without...
Under pressure: intraocular pressure and bariatric surgery
1 December 2018
| Eulee Seow
|
EYE - Glaucoma
Obesity in the general patient population is increasing. The National Institute for Health and Care Excellence recommends bariatric surgery with body-mass index (BMI) of over 40, or between 35-40 and other significant disease that could be improved with weight loss....
Vitreous loss fire drills – ophthalmic simulation improves trainee surgical competence and confidence with posterior capsule rupture scenarios
4 December 2023
| Mostafa Khalil, Chloe Shipton, Artemis Trochanis, Alan Rotchford, David Lockington
|
EYE - Cataract, EYE - Refractive
Ophthalmic trainees have reported limited exposure and low confidence regarding the management of cataract complications such as posterior capsule rupture (PCR) / vitreous loss (VL). This report evaluates the impact of a simulation-based educational training event on these concerns. Introduction...
Effects of ‘inverted U method’ Nd:YAG laser posterior capsulotomy on anterior segment and IOL tilt
4 August 2021
| Su Young
|
EYE - Cataract, EYE - Refractive
|
capsulotomy, inverted U method, phaco-vitrectomy, posterior capsular opacification, rhegmatogenous retinal detachment
The study aimed to investigate the effects of the ‘inverted U method’ Nd:YAG laser posterior capsulotomy on anterior segment parameters, decentration and tilt of intraocular lens (IOLs) and visual acuity in 76 patients with posterior capsular opacification (PCO) after previous...
Steroid implants in the treatment of post-epiretinal membrane peel macular oedema
1 February 2018
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
This is a retrospective review of 39 eyes of 37 patients treated with Ozurdex® (intravitreal dexamethasone implant) for persistent post-operative cystoid macular oedema (CMO) following vitrectomy and idiopathic epiretinal membrane (ERM) peeling. The 0.7mg implant was injected in each eye...
New AI in ophthalmology resource goes live
The Royal College of Ophthalmologists has launched a new free resource, sharing and signposting artificial intelligence as medical device (AIaMD) tools for use in ophthalmology. The online AI directory is an evolving catalogue of AIaMD tools used in research or...Practice patterns in managing exogenous endophthalmitis
1 December 2022
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Global practice patterns, endophthalmitis, exogenous endophthalmitis, ophthalmology
The authors of this study conducted a global survey of medical institutions regarding management of exogenous endophthalmitis to assess current practice patterns for this sight-threatening emergency. Thirty-six (of 42 institutions) responded and were included in the analysis. Results were as...